Cargando…
Anti-Angiogenic and Anti-Metastatic Activity of Synthetic Phosphoethanolamine
BACKGROUND: Renal cell carcinoma (RCC) is the most common type of kidney cancer, and represents the third most common urological malignancy. Despite the advent of targeted therapies for RCC and the improvement of the lifespan of patients, its cost-effectiveness restricted the therapeutic efficacy. I...
Autores principales: | Ferreira, Adilson Kleber, Freitas, Vanessa Morais, Levy, Débora, Ruiz, Jorge Luiz Mária, Bydlowski, Sergio Paulo, Rici, Rose Eli Grassi, Filho, Otaviano Mendonça R., Chierice, Gilberto Orivaldo, Maria, Durvanei Augusto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597720/ https://www.ncbi.nlm.nih.gov/pubmed/23516420 http://dx.doi.org/10.1371/journal.pone.0057937 |
Ejemplares similares
-
Antiproliferative and proapoptotic effects of DODAC/synthetic phosphoethanolamine on hepatocellular carcinoma cells
por: Luna, Arthur Cássio de Lima, et al.
Publicado: (2018) -
Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects
por: Ferreira, A K, et al.
Publicado: (2013) -
Potential antitumor activity of novel DODAC/PHO-S liposomes
por: Luna, Arthur Cássio de Lima, et al.
Publicado: (2016) -
Modulation of pro-apoptotic effects and mitochondrial potential on B16F10 cells by DODAC/PHO-S liposomes
por: Luna, Arthur Cássio de Lima, et al.
Publicado: (2018) -
Mesenchymal stem cells with rhBMP-2 inhibits the growth of canine osteosarcoma cells
por: Grassi Rici, Rose Eli, et al.
Publicado: (2012)